Advisory Services Network’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
Other funds holding ACXP
PFS
TRCT
WIM
NS
Advisory Services Network's ACXP Position: Q2 2026 in Review
Advisory Services Network sold out of Acurx Pharmaceuticals (ACXP) in Q2 2026, closing a stake of 59 shares — an estimated $219 sold.
Advisory Services Network first reported a position in ACXP in Q4 2023 and held it in 3 quarters. The position peaked at $4.53K in Q4 2023. 18 funds tracked by Wall St. Rank hold ACXP as of Q2 2026.
- Advisory Services Network reported no remaining Acurx Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 59 Acurx Pharmaceuticals shares in Q2 2026, an estimated $219.
- Advisory Services Network first reported a position in Acurx Pharmaceuticals in Q4 2023 and held it in 3 quarters.
- Advisory Services Network's Acurx Pharmaceuticals position peaked at $4.53K in Q4 2023.
- 18 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.